Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $28.8 million.

  • GeneDx Holdings' Shares Outstanding (Diluted Average) rose 6.28% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 6.28%. This contributed to the annual value of $26.9 million for FY2024, which is 10.61% up from last year.
  • GeneDx Holdings' Shares Outstanding (Diluted Average) amounted to $28.8 million in Q3 2025, which was down 3.21% from $29.8 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Shares Outstanding (Diluted Average) high stood at $210.3 million for Q3 2021, and its period low was $549,778 during Q1 2021.
  • Over the past 3 years, GeneDx Holdings' median Shares Outstanding (Diluted Average) value was $26.6 million (recorded in 2024), while the average stood at $26.3 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first surged by 2,106,262.09% in 2021, then crashed by 94.51% in 2022.
  • GeneDx Holdings' Shares Outstanding (Diluted Average) (Quarterly) stood at $108.1 million in 2021, then slumped by 90.53% to $10.2 million in 2022, then soared by 137.49% to $24.3 million in 2023, then increased by 10.61% to $26.9 million in 2024, then climbed by 6.28% to $28.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $28.8 million for Q3 2025, versus $29.8 million for Q2 2025 and $28.1 million for Q1 2025.